These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Under-prescription of statins in patients with non-alcoholic fatty liver disease. Del Ben M; Baratta F; Polimeni L; Pastori D; Loffredo L; Averna M; Violi F; Angelico F Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):161-167. PubMed ID: 27914698 [TBL] [Abstract][Full Text] [Related]
14. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy. Jialal I; Smith G Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574 [No Abstract] [Full Text] [Related]
15. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. van Stee MF; de Graaf AA; Groen AK Cardiovasc Diabetol; 2018 Jun; 17(1):94. PubMed ID: 29960584 [TBL] [Abstract][Full Text] [Related]
16. The pharmacodynamic and clinical trial evidence for statin dose. Dimmitt SB; Stampfer HG; Warren JB Br J Clin Pharmacol; 2018 Jun; 84(6):1128-1135. PubMed ID: 29393975 [TBL] [Abstract][Full Text] [Related]
17. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan. Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405 [TBL] [Abstract][Full Text] [Related]